MARKET

MTEM

MTEM

Molecular Templates Inc
NASDAQ
4.840
-0.110
-2.22%
Opening 11:51 11/29 EST
OPEN
4.990
PREV CLOSE
4.950
HIGH
5.05
LOW
4.810
VOLUME
2.27K
TURNOVER
0
52 WEEK HIGH
9.56
52 WEEK LOW
4.560
MARKET CAP
26.01M
P/E (TTM)
-0.7234
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at MTEM last week (1120-1124)?
Weekly Report · 3d ago
Weekly Report: what happened at MTEM last week (1113-1117)?
Weekly Report · 11/20 11:04
Molecular Templates Inc: Quarterly report
Press release · 11/14 07:47
Molecular Templates Inc: Current report
Press release · 11/14 07:47
Molecular Templates GAAP EPS of -$0.82 beats by $1.13, revenue of $6.8M beats by $4.34M
Molecular templates' q3 gaap eps of -$0.82 beats by $1.13, revenue of $6.8m beats by $4.34m. Molecular templates reported q3 revenue of -$6.7 million, up 60.4%.
Seeking Alpha · 11/13 22:48
Molecular Templates Q3 EPS $(0.82) Beats $(1.39) Estimate, Sales $5.73M Beat $2.46M Estimate
Molecular templates reported quarterly losses of $0.82 per share. The company reported quarterly sales of $5.73 million. Sales beat the analyst consensus estimate of $2.46 million by 133.01 percent. The company also beat quarterly losses by 87.58 percent.
Benzinga · 11/13 21:46
Weekly Report: what happened at MTEM last week (1106-1110)?
Weekly Report · 11/13 10:57
Why Wynn Resorts Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Wynn resorts shares fell 8.1% after the company reported third-quarter financial results. Invo bioscience, inc. Shares jumped 112% to $1.49 after company announced merger with naya biosciences. In addition to wynn, shares of invo, other notable gainers included par technology and synaptics.
Benzinga · 11/10 18:34
More
About MTEM
Molecular Templates, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery and development of targeted biologic therapeutics. Its drug platform technology, known as engineered toxin bodies (ETBs), leverages the resident biology of a genetically engineered form of Shiga-like Toxin A subunit to create novel therapies with potent and differentiated mechanisms of action for cancer. Its product pipeline includes MT-6402, MT-8421 and MT-0169. MT-6402 is an ETB consisting of a single chain variable fragment (scFv), with affinity for PD-L1, fused to the enzymatically active de-immunized Shiga-like toxin-A subunit (SLTA) and a class I antigen derived from the human cytomegalovirus (HCMV). pp65 protein. MT-8421, its ETB targeting CTLA-4, along with MT-6402. MT-0169 focuses on targeting CD38. CD38 is a single-chain type II transmembrane glycoprotein that is expressed by a variety of hematologic cells in an activation- and differentiation-dependent manner.

Webull offers Molecular Templates Inc stock information, including NASDAQ: MTEM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MTEM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MTEM stock methods without spending real money on the virtual paper trading platform.